Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Annals of Palliative Medicine
|
June 21, 2022
Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report
Soji Toda, Mei Kadoya, Ai Matsui, et al.
Cancer Chemotherapy and Pharmacology
|
September 30, 2025
Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib
Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, et al.
Endocrine Journal
|
May 13, 2026
Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, et al.
Case Reports in Endocrinology
|
June 11, 2025
Neoadjuvant Chemotherapy With Selpercatinib for Locally Advanced <i>RET</i> Fusion-Positive Papillary Thyroid Carcinoma: A Case Report
Mei Kadoya, Katsuhiko Masudo, Hiroyuki Ito, et al.
Gland Surgery
|
November 29, 2023
Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report
Soji Toda, Yayoi Yamamoto, Yoichiro Ookubo, et al.
Thyroid Research
|
June 6, 2026
Panel-negative strategy for suspected fusion-driven papillary thyroid carcinoma
Yoichiro Okubo, Ikki Takada, Mei Kadoya, et al.
Endocrine Journal
|
December 3, 2023
The frequency of mutations in advanced thyroid cancer in Japan: a single-center study
Soji Toda, Hiroyuki Iwasaki, Yoichiro Okubo, et al.
Anticancer Research
|
June 26, 2024
Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma
Soji Toda, Nao Saito, Mei Kadoya, et al.
JCO Precision Oncology
|
July 10, 2026
Real-World Genomic Characteristics and Prognostic Association in Advanced Papillary Thyroid Carcinoma
Soji Toda, Yukihiko Hiroshima, Hiroyuki Iwasaki, et al.
Surgical Case Reports
|
April 22, 2024
Selpercatinib for treating recurrent mixed medullary and follicular cell-derived thyroid carcinoma: a case report
Mei Kadoya, Nobuyasu Suganuma, Yuka Matsubara, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Annals of Palliative Medicine
|
June 21, 2022
Hyperthyroidism due to thyrotropin receptor antibody stimulation of metastatic thyroid carcinoma during lenvatinib treatment: a case report
Soji Toda, Mei Kadoya, Ai Matsui, et al.
Cancer Chemotherapy and Pharmacology
|
September 30, 2025
Tumor response and thyroglobulin change in differentiated thyroid carcinoma treated with dabrafenib plus trametinib
Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, et al.
Endocrine Journal
|
May 13, 2026
Efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated advanced thyroid carcinoma: Real world experience in 37 patients
Haruhiko Yamazaki, Nobuyasu Suganuma, Mei Kadoya, et al.
Case Reports in Endocrinology
|
June 11, 2025
Neoadjuvant Chemotherapy With Selpercatinib for Locally Advanced <i>RET</i> Fusion-Positive Papillary Thyroid Carcinoma: A Case Report
Mei Kadoya, Katsuhiko Masudo, Hiroyuki Ito, et al.
Gland Surgery
|
November 29, 2023
Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report
Soji Toda, Yayoi Yamamoto, Yoichiro Ookubo, et al.
Thyroid Research
|
June 6, 2026
Panel-negative strategy for suspected fusion-driven papillary thyroid carcinoma
Yoichiro Okubo, Ikki Takada, Mei Kadoya, et al.
Endocrine Journal
|
December 3, 2023
The frequency of mutations in advanced thyroid cancer in Japan: a single-center study
Soji Toda, Hiroyuki Iwasaki, Yoichiro Okubo, et al.
Anticancer Research
|
June 26, 2024
Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma
Soji Toda, Nao Saito, Mei Kadoya, et al.
JCO Precision Oncology
|
July 10, 2026
Real-World Genomic Characteristics and Prognostic Association in Advanced Papillary Thyroid Carcinoma
Soji Toda, Yukihiko Hiroshima, Hiroyuki Iwasaki, et al.
Surgical Case Reports
|
April 22, 2024
Selpercatinib for treating recurrent mixed medullary and follicular cell-derived thyroid carcinoma: a case report
Mei Kadoya, Nobuyasu Suganuma, Yuka Matsubara, et al.
Page
of 2